Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bower

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
Neurology|August 12, 2004
A limited role for DJ1 in Parkinson disease susceptibilityD M Maraganore, K Wilkes, T G Lesnick, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2006
Chemical exposures and Parkinson's disease: a population-based case-control studyRoberta Frigerio, Kevin R Sanft, Brandon R Grossardt, et al.
Journal of Parkinson'S Disease|October 10, 2019
Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based StudyCole D Stang, Pierpaolo Turcano, Michelle M Mielke, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1985
Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trialF B Cerra, N K Cheung, J E Fischer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 1, 2007
Number of children and risk of Parkinson's diseaseRoberta Frigerio, Monique M B Breteler, Lonneke M L de Lau, et al.
Annals of Clinical and Translational Neurology|May 22, 2023
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteriaNicholas H Chia, Andrew McKeon, Marinos C Dalakas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2010
A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophyAnette Schrag, Shamira Sheikh, Niall P Quinn, et al.
Nature|May 5, 1994
Humane use of animalsWilliam H Dantzler, Larry R Squire, Robert G Petersdorf, et al.
Annals of Neurology|February 26, 2005
Interaction of alpha-synuclein and tau genotypes in Parkinson's diseaseCatherine E Mamah, Timothy G Lesnick, Sarah J Lincoln, et al.
Critical Care Medicine|March 1, 1995
Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trialR H Bower, F B Cerra, B Bershadsky, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Neurology|August 12, 2004
A limited role for DJ1 in Parkinson disease susceptibilityD M Maraganore, K Wilkes, T G Lesnick, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2006
Chemical exposures and Parkinson's disease: a population-based case-control studyRoberta Frigerio, Kevin R Sanft, Brandon R Grossardt, et al.
Journal of Parkinson'S Disease|October 10, 2019
Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based StudyCole D Stang, Pierpaolo Turcano, Michelle M Mielke, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1985
Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trialF B Cerra, N K Cheung, J E Fischer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 1, 2007
Number of children and risk of Parkinson's diseaseRoberta Frigerio, Monique M B Breteler, Lonneke M L de Lau, et al.
Annals of Clinical and Translational Neurology|May 22, 2023
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteriaNicholas H Chia, Andrew McKeon, Marinos C Dalakas, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2010
A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophyAnette Schrag, Shamira Sheikh, Niall P Quinn, et al.
Nature|May 5, 1994
Humane use of animalsWilliam H Dantzler, Larry R Squire, Robert G Petersdorf, et al.
Annals of Neurology|February 26, 2005
Interaction of alpha-synuclein and tau genotypes in Parkinson's diseaseCatherine E Mamah, Timothy G Lesnick, Sarah J Lincoln, et al.
Critical Care Medicine|March 1, 1995
Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trialR H Bower, F B Cerra, B Bershadsky, et al.
Pageof 27